SCM
Soleus Capital Management Portfolio holdings
AUM
$1.45B
1-Year Return
18.23%
This Quarter Return
-7.14%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
–
AUM
$1.28B
AUM Growth
-$45.7M
(-3.5%)
Cap. Flow
+$95.6M
Cap. Flow
% of AUM
7.5%
Top 10 Holdings %
Top 10 Hldgs %
50.86%
Holding
98
New
17
Increased
22
Reduced
20
Closed
23
Top Buys
| 1 |
NovoCure
NVCR
|
$49.6M |
| 2 |
STAAR Surgical
STAA
|
$45.2M |
| 3 |
BBNX
Beta Bionics, Inc. Common Stock
BBNX
|
$41.6M |
| 4 |
Praxis Precision Medicines
PRAX
|
$33.9M |
| 5 |
Madrigal Pharmaceuticals
MDGL
|
$18.7M |
Top Sells
| 1 |
Axogen
AXGN
|
$27.9M |
| 2 |
AstraZeneca
AZN
|
$26.8M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$25.2M |
| 4 |
QuidelOrtho
QDEL
|
$24.4M |
| 5 |
Adaptive Biotechnologies
ADPT
|
$22.1M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SEPN
51
Septerna, Inc. Common Stock
SEPN
$643M
| $4.35M | 0.31% |
751,353
+75,944
| +11% | +$440K |
|
52
Geron
GERN
$893M
| $3.82M | 0.27% |
+2,400,000
| New | +$3.82M |
|
53
Sarepta Therapeutics
SRPT
$1.96B
| $3.7M | 0.27% |
+58,000
| New | +$3.7M |
|
54
ESSA Pharma
EPIX
$11M
| $3.57M | 0.26% |
2,262,026
| – | – |
|
55
Myomo
MYO
$37.7M
| $3.39M | 0.24% |
704,275
-195,725
| -22% | -$941K |
|
56
Revolution Medicines
RVMD
$7.57B
| $3M | 0.22% |
84,784
-116,300
| -58% | -$4.11M |
|
57
Delcath Systems
DCTH
$408M
| $2.96M | 0.21% |
232,722
-568,278
| -71% | -$7.23M |
|
58
Erasca
ERAS
$457M
| $2.96M | 0.21% |
2,162,162
| – | – |
|
59
InspireMD
NSPR
$101M
| $2.54M | 0.18% |
945,376
-432,752
| -31% | -$1.16M |
|
|
SION
60
Sionna Therapeutics, Inc. Common Stock
SION
$1.06B
| $2.51M | 0.18% |
+240,000
| New | +$2.51M |
|
61
Axsome Therapeutics
AXSM
$6.25B
| $1.98M | 0.14% |
+17,000
| New | +$1.98M |
|
62
AnaptysBio
ANAB
$613M
| $1.9M | 0.14% |
102,052
-311,948
| -75% | -$5.8M |
|
63
Denali Therapeutics
DNLI
$2.26B
| $1.84M | 0.13% |
+135,000
| New | +$1.84M |
|
64
Edgewise Therapeutics
EWTX
$1.64B
| $1.59M | 0.11% |
72,300
-111,000
| -61% | -$2.44M |
|
65
Y-mAbs Therapeutics
YMAB
$390M
| $1.55M | 0.11% |
349,982
| – | – |
|
|
MREO
66
Mereo BioPharma
MREO
$282M
| $1.55M | 0.11% |
686,953
-100,000
| -13% | -$225K |
|
67
CalciMedica
CALC
$43M
| $1.5M | 0.11% |
783,904
| – | – |
|
|
TECX
68
Tectonic Therapeutic, Inc. Common Stock
TECX
$314M
| $1.36M | 0.1% |
76,841
+45,000
| +141% | +$797K |
|
69
Adverum Biotechnologies
ADVM
$73.9M
| $1.26M | 0.09% |
287,246
| – | – |
|
70
OrthoPediatrics
KIDS
$524M
| $1.11M | 0.08% |
+45,000
| New | +$1.11M |
|
|
ABVX
71
Abivax
ABVX
$6.65B
| $781K | 0.06% |
125,000
| – | – |
|
72
Apogee Therapeutics
APGE
$2.26B
| $598K | 0.04% |
16,000
-54,000
| -77% | -$2.02M |
|
73
IO Biotech
IOBT
$128M
| $210K | 0.02% |
192,670
| – | – |
|
|
74
Adaptive Biotechnologies
ADPT
$1.96B
| $74.3K | 0.01% |
10,000
-2,973,142
| -100% | -$22.1M |
|
75
Crinetics Pharmaceuticals
CRNX
$3.35B
| – | – |
-85,000
| Closed | -$4.35M |
|